婴儿痉挛转型前发作持续时间与临床疗效分析

doi:10.6040/j.issn.1671-7554.0.2019.490

摘要/Abstract

摘要： 目的探讨婴儿痉挛转型前发作持续时间与临床疗效的相关性。方法回顾分析63例婴儿痉挛转型前发作的临床及脑电图资料,随访治疗效果及预后。结果患儿男40例(63.5%),女23例(36.5%)。≤1岁起病50例(79.36%),>1岁起病13例(20.64%)。患儿痉挛转型间隔时间1个月14 d~23个月,平均8.06个月,中位数是6个月,转型间隔时间≤3个月10例(15.87%),>3个月53例(84.13%)。28例(44.44%)患儿存在潜在病因,35例(55.56%)未见明显病因。视频脑电图(VEEG)证实29例患儿(46.03%)是以最先出现强直发作作为转型点,34例(53.97%)患儿混合其他发作形式出现转型点。临床痉挛发作缓解与性别、转型间隔时间有关联,差异有统计学意义(P<0.05),而与患儿起病年龄及是否存在潜在病因无关联(P>0.05)。结论男孩痉挛缓解率差于女孩,痉挛转型前发作持续时间愈短,预后愈好。

关键词: 癫痫, 婴儿痉挛, 高峰失律, 发作期, 转型期

Abstract: Objective To explore the correlation between duration of pre-transition infantile spasm and clinical efficacy. Methods The clinical and electroencephalogram data, follow-up results and prognosis of 63 infants with pre-transition spasm were retrospectively analyzed. Results There were 40 male(63.5%)and 23 female(36.5%)infants. The onset was ≤1 year in 50 patients(79.36%), and >1 year in 13 patients(20.64%). Duration of the transition was 14 days to 23 months, average 8.06 months, median 6 months. The interval of seizure transition was ≤3 months in 10 patients(15.87%), and >3 months in 53 patients(84.13%). Latent causes were found in 28 cases(44.44%)and no obvious causes were found in 35 cases(55.56%). VEEG confirmed that 29 cases(46.03%)had the first tonic episode as the transition point, and 34 cases(53.97%)had transition point mixed with other seizure types. Clinical spasm remission was related to gender and transition interval, and the differences were statistically significant(P<0.05), but not related to the age of onset and the presence of latent etiology(P>0.05). Conclusion The remission rate of spasm is worse in males than in females and those with shorter duration of spasm before transition have better prognosis.

Key words: Epilepsy, Infantile spasm, Hypsarrhythmia, Seizure, Transition

中图分类号:

R722

贾桂娟,李保敏, 雷革非, 孙若鹏, 刘心洁. 婴儿痉挛转型前发作持续时间与临床疗效分析[J]. 山东大学学报 (医学版), 2019, 57(10): 112-117.

JIA Guijuan, LI Baomin, LEI Gefei, SUN Ruopeng, LIU Xinjie. An analysis of the duration and clinical efficacy of pre-transition infantile spasm[J]. Journal of Shandong University (Health Sciences), 2019, 57(10): 112-117.

参考文献

[1] 刘晓燕. 临床脑电图学[M]. 2版. 北京: 人民卫生出版社, 2017: 285-319.
[2] 刘晓燕. 小儿脑电图图谱[M]. 北京: 人民卫生出版社, 2010: 542-543.
[3] 左启华. 小儿神经系统疾病[M]. 2版. 北京: 人民卫生出版社, 2002: 275-280.
[4] 陈莹, 张月华. 婴儿痉挛的治疗和预后研究进展[J]. 中国循证儿科杂志, 2011, 6(1): 65-70.
[5] Riikonen R, Donner M. Incidence and aetiology of infantile spasms from 1960 to 1976: a population study in Finland [J]. Dev Med Child Neurol, 1979, 21(3): 333-343.
[6] Howitz P, Platz P. Infantile spasms and HLA antigens [J]. Arch Dis Child, 1978, 53(8): 680-682.
[7] Cowan LD, Hudson LS. The epidemiology and natural history of infantile spasms [J]. J Child Neurol 1991, 6(4): 355-364.
[8] Lombrosso CT. A prospective study of infantile spasms: clinical and therapeutic correlations [J]. Epilepsia, 1983, 24(2): 135-158.
[9] Yilmaz S, Tekgul H, Serdaroglu G, et al. Evaluation of ten prognostic factors affecting the outcome of West syndrome [J]. Acta Neurol Belg, 2016, 116(4): 519-527.
[10] Riikonen R. Long-term outcome of patients with West syndrome [J]. Brain Dev, 2001, 23(7): 683-687.
[11] Gul Mert G, Herguner MO, Incecik F, et al. Risk factors affecting prognosis in infantile spasm [J]. Int J Neurosci, 2017, 127(11): 1012-1018.
[12] Appleton RE. West syndrome: long-term prognosis and social aspects [J]. Brain Dev, 2001, 23(7): 688-691.
[13] Güveli BT, Çokar Ö, Dörtcan N, et al. Long-term outcomes in patients with West syndrome: an outpatient clinical study [J]. Seizure, 2015, 25(1): 68-71.
[14] Iyer A, Appleton R. I mproving outcomes in infantile spasms: role of pharmacotherapy [J]. Paediatr Drugs, 2016, 18(5): 357-366.
[15] Arzimanoglou A, French J, Blume WT, et al. Lennox-Gastaut syndrome:a consensus approach on diagnosis, assessment, management, and trial methodology [J]. Lancet Neurol, 2009, 8(1): 82-93.
[16] Wang H. Analysis of prognostic factors in infantile spasms [J]. Chin J Pract Pediatr, 2009, 24(1): 20-21.
[17] Wray CD, Benke TA. Effect of price increase of adrenocorticotropic hormone on treatment practices of infantile spasms [J]. Pediatr Neurol, 2010, 43(3): 163-166.
[18] Overby PJ, Kossoff EH. Treatment to infantile spasms [J]. Curr Treat Options Neurol, 2006, 8(6): 457-464.
[19] Hamano SI, Nagai T, Matsuura R, et al. Treatment of infantile spasms by pediatric neurologists in Japan [J]. Brain Dev, 2018, 40(8): 685-692.
[20] Heiskala H, Riikonen R, Santavuori P, et al. West syndrome: individualized ACTH therapy [J]. Brain Dev, 1996, 18(6): 456-460.
[21] Ito M, Aiba H, Hashimoto K, et al. Low-dose ACTH therapy for West syndrome: initial effects and long-term outcome [J]. Neurol, 2002, 58(1): 110-114.
[22] Chen GL, Zhang YH, Qin J, et al. The effect of ACTH in the treatment of infantile spasm and its influenced factors [J]. Chin J Pract Pediatr, 2004, 19(7): 406-408.
[23] 蒋凤宣, 郑帼. 生酮饮食治疗婴儿痉挛31例临床分析[J]. 南京医科大学学报(自然科学版), 2018, 38(2): 257-259.
[24] Lambrechts DAJE, de Kinderen RJA, Vles JSH, et al. A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy [J]. Acta Neurol Scand, 2018, 137(1): 152-154.
[25] Song JM, Hahn J, Kim SH, et al. Efficacy of treatments for infantile spasms: a systematic review [J]. Clin Neuropharmacol, 2017, 40(2): 63-84.
[26] Dressler A, Stocklin B, Reithofer E, et al. Long-term outcome and tolerability of the ketogenic dietin drug-resistant childhood epilepsy-the Austrian experience [J]. Seizure, 2010, 19(7): 404-408.
[27] Widjaja E, Go C, McCoy B, et al. Neurodevelopmental outcome of infantile spasms: a systematic review and meta-analysis [J]. Epilepsy Res, 2015, 109(11): 155-162.
[28] Mackay MT, Weiss SK, Adams-Webber T, et al. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society [J]. Neurol, 2004, 62(10): 1668-1681.
[29] Fong CY, Osborne JP, Edwards SW, et al. An investigation into the relationship between vigabatrin, movement disorders, and brain magnetic resonance imaging abnormalities in children with infantile spasms [J]. Dev Med Child Neurol, 2013, 55(9): 862-867.
[30] Wilmshurst JM, Ibekwe RC, OCallaghan FJK. Epileptic spasms-175 years on: trying to teach an old dog new tricks [J]. Seizure, 2017, 44(11): 81-86.

相关文章 15

[1]	葛丽娟金瑞峰王纪文许新升李癊. 多药耐药基因1 C1236T多态性与癫痫患者对药物反应性的相关性[J]. 山东大学学报(医学版), 2209, 47(6): 99-102.
[2]	郑苏,陈述花,李华,邓劼,陈春红,王晓慧,冯卫星,韩萧迪,张雨佳,李娜,李莫,方方. 脑电变化和BASED评分与54例婴儿痉挛症促肾上腺皮质激素疗效的相关性[J]. 山东大学学报 (医学版), 2022, 60(9): 91-96.
[3]	李军,李保敏,杨璐. UBA5 基因突变致早发性癫痫性脑病临床特征与遗传学分析[J]. 山东大学学报 (医学版), 2022, 60(8): 58-62.
[4]	赵海青,李保敏,杨小凡,张童,李军,赵永恒,高靓. 急性间歇性卟啉病伴婴儿痉挛1例及文献复习[J]. 山东大学学报 (医学版), 2022, 60(6): 82-89.
[5]	宋洛卿,周国钰,叶翔,卢梅,赵新静. 脑淀粉样血管病相关炎症长期误诊1例报道并文献复习[J]. 山东大学学报 (医学版), 2022, 60(4): 119-122.
[6]	孙宇,陈娜,马爱华. SLC35A2基因突变致先天性糖基化障碍1例[J]. 山东大学学报 (医学版), 2021, 59(4): 113-116.
[7]	贾建华,陈思,吴倩倩,徐硕,李超,程莲,徐淑军. 立体定向脑电图引导下射频热凝毁损术治疗药物难治性癫痫的有效性分析[J]. 山东大学学报 (医学版), 2021, 59(10): 80-86.
[8]	孙永锋,刘会昭,李煜环,石磊,袁俊,钟建卫. 超声引导脑电监测在脑动静脉畸形继发癫痫手术中的应用[J]. 山东大学学报 (医学版), 2020, 58(12): 60-64.
[9]	杨夏鑫,孟明珠,纪坤乾,王晓棠,童丽丽,王爱芹,赵秀鹤. 线粒体脑肌病伴高乳酸血症和卒中样发作中癫痫发作的临床特征[J]. 山东大学学报 (医学版), 2018, 56(5): 74-80.
[10]	李岩,郭珺,王荣祺,刘永玲. 难治性癫痫相关Sturge-Weber综合征7例临床及病理分析[J]. 山东大学学报（医学版）, 2017, 55(4): 91-95.
[11]	孙永锋,刘会昭,钟建卫,王涛,袁俊,翟卫东. 超声引导电生理监测下手术治疗儿童海绵状血管瘤继发癫痫6例[J]. 山东大学学报（医学版）, 2016, 54(4): 55-59.
[12]	贾俊伟,周雪颖,李秋红,于凯,周国钰,周盛年. Annexin A7在匹罗卡品癫痫小鼠模型脑组织中的表达[J]. 山东大学学报（医学版）, 2016, 54(10): 6-10.
[13]	乔珊, 韩涛, 李文娜, 王胜军, 赵秀鹤, 杨雪, 刘学伍. 新型组蛋白脱乙酰酶抑制剂11r对癫痫持续状态大鼠的神经保护作用[J]. 山东大学学报（医学版）, 2015, 53(6): 39-43.
[14]	赵振英, 周雪颖, 刘黎青, 刘峰, 周盛年. 二肽基肽酶6在难治性颞叶癫痫患者中的表达[J]. 山东大学学报（医学版）, 2015, 53(10): 37-41.
[15]	丁娟，江虹，潘芳. 癫痫患者婚姻质量与心理应激的相关性[J]. 山东大学学报(医学版), 2013, 51(8): 99-102.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed